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Background: Chitosan oligosaccharide (COS), a deacetylated derivative of chitin, is an abundant, and renewable
natural polymer. COS has higher antimicrobial properties than chitosan and is presumed to act by disrupting/
permeabilizing the cell membranes of bacteria, yeast and fungi. COS is relatively non-toxic to mammals. By
identifying the molecular and genetic targets of COS, we hope to gain a better understanding of the antifungal
mode of action of COS.
Results: Three different chemogenomic fitness assays, haploinsufficiency (HIP), homozygous deletion (HOP), and
multicopy suppression (MSP) profiling were combined with a transcriptomic analysis to gain insight in to the mode
of action and mechanisms of resistance to chitosan oligosaccharides. The fitness assays identified 39 yeast deletion
strains sensitive to COS and 21 suppressors of COS sensitivity. The genes identified are involved in processes such
as RNA biology (transcription, translation and regulatory mechanisms), membrane functions (e.g. signalling,
transport and targeting), membrane structural components, cell division, and proteasome processes. The
transcriptomes of control wild type and 5 suppressor strains overexpressing ARL1, BCK2, ERG24, MSG5, or RBA50,
were analyzed in the presence and absence of COS. Some of the up-regulated transcripts in the suppressor
overexpressing strains exposed to COS included genes involved in transcription, cell cycle, stress response and the
Ras signal transduction pathway. Down-regulated transcripts included those encoding protein folding components
and respiratory chain proteins. The COS-induced transcriptional response is distinct from previously described
environmental stress responses (i.e. thermal, salt, osmotic and oxidative stress) and pre-treatment with these well
characterized environmental stressors provided little or any resistance to COS.
Conclusions: Overexpression of the ARL1 gene, a member of the Ras superfamily that regulates membrane
trafficking, provides protection against COS-induced cell membrane permeability and damage. We found that the
ARL1 COS-resistant over-expression strain was as sensitive to Amphotericin B, Fluconazole and Terbinafine as the
wild type cells and that when COS and Fluconazole are used in combination they act in a synergistic fashion.
The gene targets of COS identified in this study indicate that COS’s mechanism of action is different from other
commonly studied fungicides that target membranes, suggesting that COS may be an effective fungicide for
drug-resistant fungal pathogens.
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Chitin is an abundant natural polymer, second only in
biomass to cellulose [1]. It is a common constituent
of crustacean exoskeletons and arthropod cuticles [2] as
well as the cell walls of most fungi [2,3]. There is an esti-
mated 10 gigatons of chitin recycled in nature each
year [4].
Chitosan is a polymer of N-glucosamine obtained by
partial chitin N-deacetylation [1]. Acid hydrolysis or en-
zymatic cleavage of the glycosidic linkages of chitosan
chains [5], yields shorter chains of <1-10 KDa chitosan
oligosaccharides (COS). These polymers are less than
100 glucosamine monomers and are more water soluble
and readily absorbed in vivo compared to chitosan [6].
Allan and Hadwiger [7] first showed the fungicidal ef-
fect of chitosan, and since then, several studies have
examined chitosan sensitivity in different fungi [8-13].
Chitosan inhibits both hyphal growth and spore germin-
ation [14] and reduces toxin production by plant patho-
genic fungi [15]. Recently, chitosan has been shown to
increase conidiation in filamentous fungi at concentra-
tions where hyphal growth was impaired [8]. Together
these observations suggest that chitosan exerts its anti-
fungal activity by multiple mechanisms.
We used COS in our study rather than chitosan be-
cause it is more soluble and biologically active. The bio-
logical activity of chitosan and COS is dependent on its
molecular weight, degree of deacetylation and pH of the
medium [16]. High degrees of deacetylation and an
acidic pH (when most amino groups are in the free
base form) yield the highest activity against susceptible
fungi [17].
The antibiotic activity of chitosan and COS [16,18-20] is
likely due to the permeabilization of bacterial plasma
membranes [18,21]. Plasma membrane damage has also
been suggested as an explanation of the fungicidal effects
of chitosan in yeast and filamentous fungi [10,12,22,23].
Plasma membrane permeabilization by chitosan has also
been detected (indirectly) in Saccharomyces cerevisiae,
where deletion of genes encoding for proteins involved in
maintaining plasma membrane integrity increased chito-
san sensitivity [23]. Although it has been speculated that
plasma membrane permeabilization by chitosan in bac-
teria and fungi is associated with the interaction between
the positive amino groups of chitosan and the negative
charges of phospholipids, no conclusive data are
available [10,12,18].
To gain a better understanding of the mode of action
of small (< 6 kDa) chitosan oligosaccharides (COS-
5.44), and identify putative resistance mechanisms, we
performed three chemogenomic screens [24,25]. These
assays examined the effect of gene dosage to uncover
bona fide targets of COS in yeast. Two chemogenomics
assays interrogate the yeast deletion collection (~ 6000deletion strains) in a single culture in parallel. Each
deletion strain in this collection contains a unique 20-
base-pair DNA tag used to quantify the fitness of indi-
vidual strains using an oligonucleotide array [24,26].
Both essential heterozygous and non-essential homozy-
gous diploids were assayed. The haploinsufficiency pro-
filing (HIP) assay identifies genes that show increased
drug sensitivity in heterozygous deletion strains. The
heterozygous deletion strain that is most sensitive to a
given compound often indentifies its target [24,26]. The
homozygous profiling (HOP) assay identifies genes that
buffer the drug target pathway and are required for re-
sistance to the compound [24,26]. A multicopy sup-
pression profiling (MSP) screen, where genes are
overexpressed to identify those that confer resistance to
the compound of interest was also performed [25]. The
genes identified from the chemogenomic assays were
individually validated to confirm their involvement in
COS sensitivity or resistance. For five of the strains
that conferred resistance when overexpressed, we per-
formed a transcriptional analysis. The ARL1 (ADP-
ribosylation factor-like 1) gene was identified in the
HIP-HOP and MSP chemogenomics assays as being
involved in yeast resistance to COS-5.44. This gene
encodes a soluble GTPase that is a member of the Ras
superfamily and has been shown to be involved in
membrane traffic regulation [27,28]. ARL1 overexpres-
sion strains showed decreased COS-induced permeabil-
ity compared to wild type cells. Because COS is a cell
stress causing agent, we compared the transcriptional
response induced by COS to those of other environ-
mental stressors and ascertained whether an environ-
mental stress pretreatment could provide resistance to
COS. Finally, we evaluated whether a COS-resistant
ARL1 overexpressing strain is also resistant to other
antifungal compounds.
Results
Sensitivity to chitosan and COS-5.44 treatment in the
yeast deletion pools
A scheme summarizing the experiments and analyses
performed in this study is shown in Figure 1. We first
compared yeast sensitivity to deacetylated chitosan (ap-
proximately 70 kDa, 80% deacetylated) and to chitosan
oligosaccharide (COS) (5.44 kDa, 97% deacetylated).
COS (Additional file 1: Figure S1A) had considerably
higher antifungal activity than chitosan at equivalent
concentrations (Additional file 1: Figure S1B). Because
of this, it is easier to more consistently manufacture this
form, we decided to use COS as the antifungal agent.
The heterozygous and homozygous yeast deletion collec-
tions were grown in YPD with 91.1 μg/ml COS-5.44, a
concentration that inhibited yeast wild type growth by
10 – 20% compared with the control (Figure 2B). In the
Figure 1 (See legend on next page.)
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Figure 1 Experimental approach used to identify and characterize genes that confer resistance to chitosan oligosaccharide (COS).
Three chemogenomic assays were used: Haploinsufficiency profiling (HIP), homozygous profiling (HOP) and multicopy suppression profile (MSP).
(1) Heterozygous, homozygous deletion pools and multicopy suppression pool were grown competitively in the presence of COS-5.44. If a gene
is required to grow in the presence of COS, the corresponding deletion strain will grow more slowly and therefore will be underrepresented.
Cells overexpressing a gene that suppresses sensitivity will growth faster and will be overrepresented in the MSP pool. (2) Genomic DNA was
isolated from cells prior to and after the HIP-HOP assays, and plasmid purification from the COS treated MSP pool was carried out. (3) Barcodes
were PCR amplified for HIP-HOP assays as well as the plasmid inserts of MSP. (4) PCR products (barcodes and plasmid inserts) were hybridized to
a TAG4 array. Intensity of treatment samples is compared with intensity of a control sample to determine relative abundance (~ fitness). (5)
Sensitive deletion strains and constructed overexpressing strains were individually confirmed. (6) Five resistant overexpressing strains that were
also sensitive as deletion strains were selected for transcriptome analysis. Overexpressing strains and vector control were grown in the presence
of COS (112.5 μg/ml) and cells were harvested before COS treatment and after 60 min of COS treatment. (7) RNA was isolated from harvested
cells, cDNA synthesized and labelled with fluorescent dyes. (8) Labelled samples were hybridized to expression microarrays. Transcriptional
changes were indentified by differential expression analysis. Figure modified from Ericson et al. (2010).
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COS-5.44 were indentified (22 homozygous and 17 het-
erozygous; log2 ratio ≥ 3.5, see Methods; Table 1, Add-
itional file 2: Table S1).
A previous global fitness analysis, similar to the HIP-
HOP assay we performed, identified 101 chitosan sensi-
tive homozygous and three heterozygous deletion
strains, [23]. Approximately 10% of the homozygous de-
letion strains found in their study were among the genes
identified in our screen (ARL1, IMP2’, APN1, RSC1,
SNF8, DFG16, VPS66, YAP3, SSN8), but none of the
three heterozygous deletions strains corresponded to
those identified in our screen.
Biological processes (defined by Gene Ontological
terms) associated with the COS-5.44 sensitive deletion
strains were determined using gene set enrichment ana-
lysis (GSEA) [29]. The enriched processes included
RNA biology (transcription, translation and regulatory
mechanisms), membrane functions (e.g. transport and
targeting), membrane structural components (e.g. pro-
teins), cell division (spindle body and microtubules) and
proteasome processes (structural and regulatory func-
tions; Figure 2C, FDR ≤ 0.1, see Methods). Similar GO
terms showed altered fitness in the presence of chitosan
in a similar fitness analysis [23].
To confirm whether the 39 deletion strains were sensi-
tive to COS on their own, we tested each strain individu-
ally and found that 21 (~50%) were inhibited by COS
(Table 1).
Resistance to COS-5.44 treatment in the multicopy
suppression profiling pool
MSP assays involve the transformation of yeast with a
multicopy suppression plasmid library containing ran-
dom fragments of approximately 7 kbp pieces of DNA.
The MSP assay was performed with 101.25 – 250.0 μg/
ml COS-5.44 and it was determined that 112.5 μg/ml
COS-5.44 inhibited wild type yeast growth by at least
70% (Figure 2B). Yeast containing suppression plasmids
that provide resistance to 112.5 μg/ml COS-5.44 willexpand more quickly than the rest of the yeast of the
population. Genomic DNAs from a resistant population
and a transformed but untreated population are
extracted and hybridized to ORF microarrays to identify
genes present in multicopies in the resistant population.
Two independent replicates of the MSP screen identi-
fied a total of 68 genes as putative suppressors of COS-
5.44 sensitivity (Additional file 1: Figure S2). The
random genomic DNA fragments in the multicopy sup-
pression plasmid library contain on average 2 – 3 yeast
genes per fragment [25]. Only one gene in each frag-
ment is likely responsible for resistance; therefore we
expected only 33-50% of these genes to be confirmed as
suppressors of COS-5.44 (see below and Additional file
2: Table S2). There were 42 and 32 suppressing genes in
replicates 1 and 2 respectively with only 6 genes in com-
mon (Additional file 1: Figure S2). The 6 genes were:
PKR1, a V-ATPase assembly factor in the endoplasmic
reticulum (ER) which functions with other V-ATPase as-
sembly factors to efficiently assemble the V-ATPase
membrane sector; COX5A, subunit Va of cytochrome c
oxidase, involved in mitochondrial electron transport;
FLO1, a lectin-like cell wall protein involved in floccula-
tion that binds to mannose on the surface of other cells;
VAC7, a vacuolar membrane protein involved in inherit-
ance and vacuole morphology; RPL20A, a large riboso-
mal subunit protein; and MSG5, a dual specificity
phosphatase protein required for maintenance of low
level signaling through the cell integrity pathway which
regulates and is regulated by Slt2p. Three of these genes,
PKR1, VAC7 and MSG5, were also found to be sensitive
to COS when tested as single heterozygous deletion
strains. Among the suppressing genes found in replicate
2, ARL1, a gene encoding a GTPase protein, was identi-
fied. This gene was found to be sensitive to COS-5.44 as
a deletion strain in the HIP-HOP assay (Table 1).
Confirmation of COS suppressing strains
After the identification of putative resistant strains we
tested each strain individually. From the 68 candidate
Figure 2 Chitosan oligosaccharide molecule, screen and biological process associated with sensitive deletions strains. A) Chitosan
molecular structure. B) Chitosan oligosaccharide screen in wild type yeast (BY4743) at 5 concentrations (91.1 – 112.5 μg/ml) in 0.5X YPD pH 5.
Optical density readings were taken every 15 min over 20 hrs using a Tecan Genios reader (see Methods). C) Biological processes associated with
chitosan oligosaccharide (COS) sensitive deletion strains. A node represents a biological process significantly enriched in the COS-5.44 HIP-HOP
assay (FDR≤ 0.1, see Methods). The node size correlates to the number of genes annotated to that functional category. The width of the edge
correlates to the degree of gene overlap between the 2 connected categories. If the overlap coefficient is less than 0.5, edges are not shown
(see Methods). Cluster membership is shown by node color, where clustering is based in degree of overlap among categories. Bar plots show the
sensitivity scores of the genes that contributed to the functional enrichment of the cluster, border color surrounding the plot correlated with the
nodes in the cluster. The top 10 genes in each cluster category are shown in each plot. Heterozygous strains are marked with a black dot.
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Table 1 Top 39 characterized sensitive deletion strains found in the HIP-HOP assays above 3.5 log 2 ratio
probeid COS-5.44
(91.1 μg/ml)
(log2ratio)
Gene SGD_description Fitness
score (avg)2
Deletion
pool source3
YBR 164C 4.686 ARL1 Soluble GTPase of the RAS superfamily, with a role in
regulation of membrane traffic mainly regulates
pottassium influx; similar to ADP-ribosylation factor.
0.756 HOM
YBR257W 3.534 POP4 subunit of both RNase MRP, which cleaves pre-rRNA,
and nuclear RNase P, which cleaves tRNA precursors
to generate mature 5′ends; binds to the RPR1 RNA
subunit in RNase P.
0.9963 HET
YDL060W 3.769 TSR1 Protein required for processing of 20S pre-rRNA in the
cytoplasm associates with pre-40S ribosomal particles.
0.8887 HET
YDL213C 5.101 NOP6 rRNA-binding protein required for 40S ribosomal subunit
biogenesis; contains an RNA recognition motif (RRM).
0.8854 HOM
YDR300C 4.371 PRO1 Gamma-glutamyl kinase, catalyzes the first step in proline
biosynthesis.
0.8521 HOM
YDR320C 3.571 SWA2 Auxilin-like protein involved in vesicular transfort; clathrin-
binding protein required for uncoating of clathrin-
coated vesicles
0.9621 HOM
YDR324C 3.636 UTP4 Subunit of U3 involved in production of 18S rRNA,
assembly of small ribosomal subunit and transcription
of 35S rRNA transcript, member of t-Utp subcomplex.
0.761 HET
YDR389W 4.281 SAC7 GTPase activating protein (GAP) for Rho1p, involved
in signaling to the actin cytoskeleton, null mutations
suppress tor2 mutations and temperature sensitive
mutations in actin; potential Cdc28p substrate.
0.8768 HOM
YDR455C 3.577 YDR455C Partially overlaps the verified gene YDR456W. 0.9312 HOM
YGL045W 4.229 RIM8 Protein involved in proteolytic activation of Rim 101p
in response to alkaline pH; interacts with ESCRT-1 subunits
Stp22p and Vps28p; member of the arrestin-related
trafficking adaptor family.
0.896 HOM
YGR056W 3.72 RSG1 Component of the RSC chromatin remodeling complex;
required for expression of mid-late sporulation-specific
genes.
0.8656 HOM
YGR122W 3.719 YGR122W Probable ortholog of A. nidulans PalC, which is involved
in pH regulation and binds to the ESCRT-III complex;
null mutant does not properly process Rim 101p and
has decreased resistance to rapamycin.
0.9913 HOM
YGR246C 3.887 BRF1 TFFIIIB B-related factor, one of three subunits of RNA
polymerase III transcription initiation factor TFFIIIB,
binds TFIIIC and TBP and recruits RNA pol III to promoters,
amino-terminal half is homologous to TFIIB.
0.9782 HET
YHL009C 3.625 YAP3 Basic leucine zipper (bZIP) transcription factor. 0.8854
YIL019C 3.59 FAF1 Protein required to pre-rRNA processing and 40S
ribosomal subunit assembly.
0.9603 HET
YIL022W 3.931 TIM44 Essential component of the Translocase of the inner
Metochondrial membrane; tethers the import motor
and regulatory factors (PAM complex) to the translocation
channel (Tim23p-Tim17p core complex).
0.8167 HET
YIL048W 3.83 NEO1 Putative aminophospolipid translocase (flippase) involved
in endocytosis and vacuolar biogenesis.
1.0734 HET
YIL075C 3.653 RPN2 Subunit of the 26Sproteasome, substrate of the
N-acetyltransferase Nat1p.
0.9832 HET
YIL154C 4.315 IMP2 Transcriptional activator involved in maintenance of
ion homeostasis and protection against DNA damage
caused by bleomycin and other oxidants.
0.2516 HOM
YJL002C 3.515 OST1 Alpha subunit of the oligosaccharyltransferase
complex of the ER lumen, which catalyzes asparagine-
linked glycosylation of newly synthesized proteins.
1.0555 HET
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Table 1 Top 39 characterized sensitive deletion strains found in the HIP-HOP assays above 3.5 log 2 ratio (Continued)
YGL188C 3.656 BUD19 ORF overlaps the verified gene RPL39 by 88%f; diploid
mutants displays a weak budding pattern phenotype
in a systematic assay.
1.0087 HOM
YJR102C 3.755 VPS25 Component of the ESCRT-II complex, which is involved
in ubiquitin -dependent sorting of proteins into the
endosome.
1.0011 HOM
YKL114C 4.271 APN1 Apurinic/apyrimidinic endonuclease, 3′-repair diesterase
involved in repair of DNA damage by oxidation
and alkylating agents; also functions as a 3′-5′ exonuclease
to repair 7,8-dihydro-8-oxodeoxyguanosine.
0.8878 HOM
YKR024C 3.506 DPB7 Putative ATP-dependent RNA helicase of the dead
-box family involved in ribosomal biogenesis.
0.9795 HOM
YKR025W 4.622 SNF7 One of four subunits of the endosomal sorting complex
required for transport III (ESCRT-III); involved in the
sorting of transmembrane proteins into the multivesicular
body (MVB) pathway.
0.8599 HOM
YLR100W 3.929 ERG27 3-keto sterol reductase, catalyzes of the last three steps
required to removed two C-4 methyl groups from an
intermediate in engosterol biosynthesis; mutants are
sterol auxotrophs.
0.8809 HET
YLR147C 3.525 SMD3 Core Sm protein Sm D3; part of heteroheptameric complex
that is part of the spliceosomal U1, U2, U4, and U5 snRNPs;
homolog of human Sm D3.
1.0582 HET
YLR223C 3.633 IFM1 Coactivator that regulates transcription of ribosomal protein
(RP) genes; recruited to RP gene promoters during optimal
growth conditions via Fhl1p; subunit of CURI, a complex
that coordinates RP production and pre-rRNA processing.
0.9691 HET
YLR378C 3.539 SEC61 Essential subunit of Sec61 complex (Sec61p, Sbh1p, and
Sss1p); with Sec63 complex forms a channel for SRP-dependent
protein import and retrograde transport of misfolded
proteins out of the ER.
0.8717 HET
YNL025C 3.581 SSN8 Cyclin-like component of the RNA polymerase II holoenzyme,
involved in phosphorylation of the RNA polymerase II
C-terminal domain, in glucose repression and telomere
maintenance.
0.823 HOM
YNL287W 3.66 SEC21 Gamma subunit of coatomer, a heptameric protein complex
that together with Arf1p forms the COPI coat; involved in ER
to Golgi transport of selective cargo.
0.8959 HET
YNR046W 4.047 TRM112 Subunit of tRNA methyltransferase (MTase) complexes in
combination with Trm9p and Trm11p; subunit of complex
with Mtq2p that methylates Sup45p (eRF1) in the temary
complex eRF1-eRF3-GTP.
0.9906 HET
YOR014W 3.844 RTS1 B-type regulatory subunit of protein phospatase 2A (PP2A);
homolog of the mammalian B’subunit of PP2A.
0.9832 HOM
YOR030W 3.669 DFG16 Probable multiple transmembrane protein, involved in
diploid invasive and pseudohyphal growth upon nitrogen
starvation; required for accumulation of processed Rim101p.
1.0307 HOM
YOR080W 4 DIA2 Origin-binding F-box protein that forms an SCF ubiquitin
ligase complex with Skp1p and Cdc53p; plays a role in DNA
replication, involved in invasive and pseudohyphal growth.
1.1312 HOM
YOR117W 3.506 RPT5 One of the six ATPases of the 19S regulatory particle
(26S proteasome) involved in the degradation of
ubiquintinated substrates; recruited to the GAL1-10 promoter
region upon induction of transcription; similar to human TBP1.
0.8955 HET
YOR244W 3.5 ESA1 Catalytic subunit of the histone acetyltransferase complex
(NuA4) that acetylates four conserved internal lysines of histone
H4N-terminal tail; required for cell cycle progression and
transcriptional silencing at the rDNA locus.
0.8716 HET
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Table 1 Top 39 characterized sensitive deletion strains found in the HIP-HOP assays above 3.5 log 2 ratio (Continued)
YPL002C 3.679 SNF8 Component of the ESCRT-II complex, which is involved in
ubiquitin-dependent sorting of proteins into the endosome;
appears to be functionally related to SNF7; involved in
glucose derepression.
0.8925 HOM
YPR139C 3.643 VPS66 Cytoplasmic protcin of unknown function involved in
vacuolar protcin sorting.
0.8768 HOM
1 COS-5.44 log2 ratio is calculated from tag4 array data for each tag of each deletion strain. COS-5.44 log2 ratio = log2 (μc - bg)/(μt - bg), where μc is the mean
intensity of the control sample, μt is the mean intensity of the treated samples, and bg is the mean intensity of the unassigned probes. This score is proportional
to the log2 ratio of cells present in the control sample versus the treatment sample (i.e. deletion strains exposed to 91.1 μg/ml of COS) [24].
2 Fitness score (W) is estimated from the average growth curves (as measured by optical density) of a given strain in the presence and absence of COS after 20 h.
The fitness scores from three individual colonies of each deletion strain grown in triplicate (i.e. 9 cultures for each strain) were used to calculate the average. This
score takes into account the growth of the wild type and deletion strain in control conditions as well as treatment conditions. Wc=wtc/stc; Wt =wtt/stt, where Wc
is the fitness score under control (no drug) conditions, Wt is the fitness score after treatment, wt is doubling time of wild type strain, st is doubling time of the
deletion strain, c is control conditions, t is treatment (COS) conditions. Normalized fitness (W) = avg Wt/avg Wc [24]. A fitness score less than 1 indicates that the
strain is sensitive [24]. A minimum difference of 0.1 (10%) was used as a cut-off to consider a strain sensitive.
3 Deletion pool source identifies which pool of deletion strains the deleted strain came from. HET - heterozygous essential deletions strains, HOM - homozygous
deletion strains.
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strains each containing a single putative resistance gene
were obtained from a collection of ORFs whose expres-
sion is driven by native promoters [30] see Methods.
Twenty-one (~31%) of the putative suppressor genes
conferred resistance to COS-5.44 when tested in this
manner (Table 2). COS-5.44 resistant overexpressing
strains were able to grow in 112.5 μg/ml COS-5.44 while
the wild type (transformed with an empty vector) was un-
able to grow (Figure 3B).
Among the confirmed genes that confer resistance to
COS-5.44 were two essential genes: RBA50 (YDR527W),
a gene whose protein product is involved in transcrip-
tion, and ARP2 (YDL029W), a gene encoding actin
related protein 2, a subunit of the Arp2/3 complex
which is required for the motility and integrity of cor-
tical actin patches. Among the remaining 19 non-
essential genes, a diversity of functions were found, such
as a sterol reductase, a heat shock protein, ADP-
ribosylation factors, soluble GTPases, alpha tubulin, and
a ubiquitin conjugation enzyme. Putative suppressors of
COS antifungal action in yeast were all tested as hetero-
zygous deletion strains and from the 21 resistant overex-
pressing strains, 11 were found to be sensitive when
tested as heterozygous deletion strains (Table 2). Five
genes that provided COS resistance when overexpressed
or sensitivity as a heterozygous or homozygous deletion
strain were selected for further study primarily based
on the known or putative functions of the genes. More
specifically we selected genes with roles in signalling
pathways, cell or membrane integrity, or transcription
regulation.
We selected the following 5 overexpressing strains:
ARL1, which encodes a GTPase involved in membrane
trafficking, was selected because it was found in the
HIP-HOP assay as a sensitive homozygous deletion
strain and in the MSP assay as a multicopy suppressor.
The other overexpressing strains we selected were:BCK2 and MSG5, which are both involved in cell integ-
rity pathways; ERG24, a gene involved in ergosterol syn-
thesis; and RBA50 (mentioned above). BCK2 is a Ser-
Thr rich protein with protein kinase C activity that acts
in signal transduction. Overexpression of BCK2 can res-
cue defects in a cwh43Δ mutant that displays several cell
wall defects [31]. BCK2 overexpression can also suppress
the cell lysis defects seen when the kinases Mpk1 and
Pck1 are deleted [32]. MSG5 encodes a protein phos-
phatase involved in cell cycle control through the depho-
sphorylation of MAPK and is required for restricting
signaling by the cell integrity pathway in yeast [33]. The
inhibition of MAPK signaling leads to inhibition of cell
differentiation and cell division [34]. The functions of
ARL1 and ERG24 and their potential roles in chitosan
resistance are described in more detail in the Discussion.
The fitness of all overexpressing strains compared to
an empty vector control and the corresponding hetero-
zygous deletion strains were assessed. In the presence of
COS-5.44, the overexpressing strains always grew better
than the vector control (Figure 3B, showing results of
ARL1) and the corresponding deletion strain demon-
strated reduced fitness (Figure 3D). In the absence of
the COS-5.44, no growth differences were observed
among each overexpressing strain or deletion strains
(tested in triplicate) compared with the vector control,
indicating the absence of inherent fitness defects
(Figure 3A and 3C).
Transcriptional response to COS
To identify the transcriptional changes caused by expos-
ure to COS-5.44, wild type (vector control) cells, were
exposed to COS for 1 h, total RNA extracted, and a
microarray analysis was performed. A total of 335 genes
were differentially expressed in response to COS-5.44
(P-value < 0.05 and log2 fold change > 1 or <−1).
A GSEA was performed for the entire transcription
data set and among the up-regulated transcripts, we
Table 2 Twenty-one yeast overexpression strains confirmed as suppresors of sensitivity to COS-5.44
ORF Gene Resistance
confirmed
Fitness score of
resistance (avg)3
Sensitivity confirmed
(HET deletion strain)
Fitness score of
sensitivity (avg)4
Description from SGD
YBR164C ARL11 yes 1.870 yes 0.756 Soluble GTPase of the Ras perfamily, with a role in regulation of
membrane traffic mainly r ulates potassium influx;
similar to ADP-ribosylation ctor.
YBR166C TYR1 yes 1.381 no 1.035 Prephenate dehydrogenas involved in tyrosine biosynthesis,
expression is dependent o phenylalanine levels.
YDL029W ARP2 yes 1.609 no 1.023 Essential component of th Arp2/3 complex involved in endocytosis
and membrane growth an polarity. A conserved actin nucleation
center required for the mo lity and integrity of actin patches.
YDR171W HSP42 yes 1.372 no 1.135 Small heat shock protein ( SP) with chaperone activity involved
in cytoskeleton reorganiza n after heat shock; forms barrel-shaped
oligomers that suppress u olded protein aggregation.
YDR524C AGE1 yes 1.783 no 1.106 ADP-ribosylation factor (AR ) GTPase activating protein (GAP) effector,
involved in the secretory a d endocytic pathways.
YDR527W RBA501 yes 1.407 yes 0.899 Protein involved in transcr tion; interacts with RNA polymerase II
subunits Rpb2p, Rpb3, and pb11p; has similarity to human RPAP1.
YER048C CAJ1 yes 1.845 no 0.995 Nuclear type II J heat shoc protein of the of the E. coli dnaJ family,
binds, to non-native subst tes for presentation to Ssa3p, may function
during protein translocatio , assembly and disassembly.
YER167W BCK21 yes 1.365 yes 0.890 Protein rich in serine and reonine residues involved in protein kinase
C signaling pathway, whic controls cell integrity; overproduction
suppresses pkc 1 mutation
YJL046W AIM22 yes 1.258 no 0.908 Putative lipoate-protein lig e, required along with Lip2 and Lip5 for
lipoylation of Lat1p and Kg 2p.
YKL208W CBT1 yes 1.265 no 0.930 a role in 3′end processing f the COB pre-mRNA; displays genetic
interaction with cell cycle- gulated kinase.
YLR193C UPS1 yes 1.201 no 0.953 Mitochondrial intermembr e space protein that regulates mitochondrial
cardiolipin levels, null has fects in Mgm1p processing, integrity of
mitochondrial inner memb ne complexes; ortholog of human PRELI.
YLR285W NNT1 yes 1.448 no 1.184 Putative nicotinamide N-m thyltransferase, has a role in rDNA silencing
and in the lifespan determ ation.
YML124C TUB3 yes 1.763 no 1.227 Alpha-tubulin; associates w h beta-tubulin (Tub2p) to form tubulin dimer,
which polymerizes to form icrotubules; expressed at lower level than Tub1p.
YMR123W PKR12 yes 1.350 yes 0.866 V-ATPase assembly factor, nctions with other V-ATPase assembly factors
in the ER to efficiently asse ble the VATPase membrane sector (VO).
YNL053W MSG51 yes 1.454 yes 0.874 Dual-specificity protein ph phatase; required for maintenance of a low
level of signaling through e cell integrity pathway, adaptive response to
pheromone; regulates and regulated by Slt2p; dephosphorylates Fus3p.
YNL054W VAC72 yes 1.387 yes 0.873 Integral vacuolar membran protein involved in vacuole inheritance and
morphology; activities Fab kinase activity under basal conditions anfd
also after hyperosmotic sh k.
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Table 2 Twenty-one yeast overexpression strains confirmed as suppresors of sensitivity to COS-5.44 (Continued)
YNL218W MSG12 yes 1.214 yes 0.899 Protein with DNA-dependent ATPase and ssDNA annealing activities
involved in maintenance of genome; interacts functionally with DNA
polymerase delta; homolog of human WHIP.
YNL280C ERG241 yes 1.275 yes 0.893 C-14 sterol reductase, acts in ergosterol biosynthesis; mutants accumulate
the abnormal sterol ignosterol (ergosta-8, 14 dienol).
YNR057C BIO42 yes 1.246 yes 0.885 Dethiobiotin synthetase, catalyzes the third step in the biotin biosynthesis
pathway; BIO4 is in a cluster of 3genes (BIO3, BIO4, and BIO5) that mediate
biotin synthesis.
YPL053C KTR62 yes 1.616 yes 0.861 Probable mannosylphosphate transferase involved in the synthesis of core
oligosaccharides in protein glycosylation pathway; member of the
KRE2/MNT1 mannosyltransferase family.
YPL106C SSE12 yes 1.253 yes 0.896 ATPase that is a component of the heat shock protein Hsp90 chaperone
complex; binds unfolded proteins; member of the heat shock protein 70
(HSP70) family; localized to the cytoplasm.
1 Genes selected for transcriptomic analysis.
2 Overexpressing strains confirmed as suppressors when overexpressed and sensitive when tested as deletion strains.
3–4 Fitness score (W) is estimated from the average growth curves (as measured by optical density) of a given strain in the presence and absence of COS after 20 h. Data shown corresponds to deletion strains exposed
to 91.1 μg/ml and overexpressing strains to 112.5 μg/ml of chitosan oligosaccharide. The fitness scores from three individual colonies of each overexpressing or deletion strain grown in triplicate (i.e. 9 cultures for
each strain) were used to calculate the average. This score takes into account the growth of the wild type and overexpressing or deletion strain in control conditions as well as treatment conditions. Wc=wtc/stc;
Wt =wtt/stt, where Wc is the fitness score under control (no drug) conditions, Wt is the fitness score after treatment, wt is doubling time of wild type strain, st is doubling time of the overexpressing or deletion strain, c
is control conditions, t is treatment (COS) conditions. Normalized fitness (W) = avg Wt/avg Wc [24]. A fitness score less than 1 indicates that the strain is sensitive, a fitness score above 1 indicates that the strain is
resistant [24]. Means that the strain has a treatment induced growth defect, a minimum difference of 0.1 (10%) was used as a cut-off to consider a strain sensitive.
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Figure 3 Confirmation of COS-5.44 resistance in the Arl1 overexpressing strain and sensitivity of the corresponding heterozygous
deletion strain. The overexpression of ARL1 does confer resistance to COS-5.44 (112.5 μg/ml) compared with the wild type (vector control) that
is not able to grow at this concentration. The heterozygous deletions strain (arl1Δ) shows sensitivity to COS-5.44 (91.1 μg/ml). A) Growth curves
of ARL1 and wild type (vector control) growth in the vehicle. B) Growth curves of Arl1 overexpressing and wild type strains growth with COS-5.44
(112.5 μg/ml). C) Growth curves of the heterozygous deletion (arl1Δ) and wild type strain grown with the vehicle. D) Growth curves of
heterozygous deletion (arl1Δ) and wild type strains grown with COS-5.44 (91.1 μg/ml). Optical density readings were taken every 15 min over
20 hrs using a Tecan Genios reader. Tecan ODs were converted to conventional 1 mm path length cuvette ODs using a calibration function
provided by Ericson et al. 2010, [24]. Similar behaviour was observed for the rest of the selected overexpressing strains (Bck2, Erg24, Msg5 and
Rba50) deduced to be resistant to chitosan oligosaccharide COS-5.44 from the MSP screen. The heterozygous deletion strains from these genes
(bck2Δ, erg24Δ, msg5Δ and rba50Δ) were also individually tested for sensitivity to COS-5.44 (91.1 μg/ml). Three colonies of each strain were
grown in triplicate and compared with the wild type in the presence of the COS-5.44 and the vehicle (1% DMSO).
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complex biogenesis, and mitochondria translation and
organization as enriched biological processes (P < 0.005).
For the down-regulated transcripts, the enriched terms
included glycosylation, transmembrane transport, and
sterol and lipid biosynthesis. For the overexpressing
strains that provided resistance to COS (see below), the
majority of these biological processes had the opposite
characteristic (i.e. enriched biological processes among
up-regulated transcripts in the wild type were enriched
among down-regulated transcripts in the overexpression
strains). A comparison of the transcriptional profiles of
the COS-5.44 treated wild type cells in this study with
the chitosan treated 60 min profile from another similar
study, [22] was performed (Additional file 1: Figure S3,
Additional file 2: Table S13). As might be expected, there
was considerable overlap among enriched biological pro-
cesses between the two studies (Additional file 1: Figure
S3, Additional file 2: Table S13), and included such
terms as cell wall organization, ATP production, andoxidative phosphorylation as being enriched among up-
regulated transcripts. Ribosome biogenesis and poly-
phosphate metabolic processes were enriched among
down-regulated transcripts. There were also several bio-
logical processes that showed up as having opposite
enrichments in the two studies. For example, sterol/
ergosterol/lipid biosynthesis was observed as a down-
regulated process in our study while these were up-
regulated in Zakrzewska and co-workers study. While it
is not clear why some processes show opposite enrich-
ments in the two studies, we do know that different
types and amounts of anti-fungal agents were used,
Zakrzewska et al. exposed the yeast cells to fragmented
chitosan at an IC10 - 15 and in this study, cells were
exposed to COS-5.44 at an IC70 – 80.
Transcriptome analysis of the COS-5.44 resistant strains
To gain a further understanding on the mode of action
and mechanisms of resistance to COS, we performed a
transcriptome analysis of the 5 overexpressing strains
Figure 4 (See legend on next page.)
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Figure 4 Differentially expressed genes in COS-5.44 resistant yeast overexpressing strains in the presence of COS-5.44. One thousand
two hundred and twenty genes showed a significant change in expression in at least one of the overexpressing strains compared with the wild
type (P-value≤ 0.05 and log2 fold change≥ 1 or≤−1). Clustering of the 1220 genes with significant change in expression was based in similarity
(see methods). A–D) Subsets of up-regulated genes among the 5 overexpressing strains. E–H) Subsets of down-regulated genes among the 5
overexpressing strains.
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in GEO under GSE32888). Each overexpressing strain
and the wild type (vector control) were treated with
COS-5.44 for 1 h or mock treated with vehicle alone
and RNA was isolated from each sample. The RNA was
converted to labeled cDNA and hybridized to Nimble-
Gen expression microarrays (see Methods). We per-
formed two sets of analyses. The first analysis was
designed to find genes differentially expressed genes in
each overexpression strain compared to wild type in the
absence of COS in order to see if overexpression of the
gene in question changed the transcriptional profile (and
potentially the physiology or structure of the cell). The
second analysis was designed to find differentially
expressed genes in each overexpression strain compared
to wild type in the presence of COS to see if the over-
expression strains responded differently to COS than
wild type.
In the first analysis, we identified 184 genes with differ-
ential expression in at least one of the 5 overexpressing
strains compared with the wild type (vector control) with-
out COS-5.44 treatment (Additional file 1: Figure S4,
Additional file 2: Table S3; P-value≤ 0.05 and log2 fold
change≥ 1 or≤−1). Each of the 5 overexpressing strains
showed increased expression of the gene contained in the
transformation vector (Additional file 1: Figure S4 A-D).
There was a subset of 13 highly up-regulated genes in the
ARL1 and RBA50 strains (Additional file 1: Figure S4 A)
including genes encoding heat shock proteins, acid phos-
phatases, inorganic phosphatases, and transmembrane
transporters. Several genes involved in oxidative phos-
phorylation, amino acid and carbohydrate metabolic pro-
cesses and biosynthesis, and mitochondrial ATP synthesis
and electron transport were up-regulated (Additional file
1: Figure S4 D).
Transcriptome analysis following COS-5.44 treatment
was performed and 1220 genes (~589 up- and ~631
down-regulated) showed significant differential expres-
sion relative to the wild type under the same growth
conditions (P-value < 0.05 and log2 fold change ≥ 1 or
≤−1, Additional file 2: Table S4) in at least one of the 5
overexpressing strains (Figure 4). Significantly over
represented biological processes identified by enrich-
ment analyses [35,36] in the 589 differentially up-
regulated genes included transcription, cell cycle, protein
modification, stress response and RAS signal transduc-
tion (Figure 4A-E). Down-regulated genes were enrichedfor biological processes included protein folding, protein
complex assembly, and respiratory chain complex genes
(Figure 4F-H).
The primary biological processes associated with the 5
overexpression strains in the presence of COS (Table 2)
were: membrane signalling functions (ARL1, BCK2,
MSG5), transcription (RBA50) and ergosterol synthesis
(ERG24). To gain insight into the potential mechanisms
of COS resistance for each overexpressed gene, enrich-
ment maps were constructed from the entire transcrip-
tion data set, GSEA analyzed, for each of the COS
treated overexpressed strains (Figure 5 and Additional
file 1: Figures S5- S9). Genes that were down-regulated
to various degrees in all 5 strains were associated with
processes such as cell energy generation (mitochondrial
biology, ATP metabolism, energy storage metabolites)
and associated by-products (oxidative stress). Most over-
expressing strains (ARL1, ERG24 and RBA50) displayed
up-regulated genes involved in cell cycle progression
(mitosis/meiosis, chromatin dynamics and modification
and sporulation) and transcription. Taken together
these results suggest that the overexpression resistant
strains had an overall reduction in energy production
and an increase in cell proliferation in response to
COS-5.44 perturbation compared to wild type cells.
We confirmed some of the global transcriptional
changes by qRT-PCR. ARL1 overexpression was con-
firmed in Arl1 overexpressing strains. For all of the
genes selected, the qRT-PCR results were always in the
same direction as the microarray results (i.e. increased
transcript levels for a given gene found using microar-
rays was also found to be increased by qRT-PCR) but
the dynamic range for the transcript changes was
greater in the qRT-PCR assays. COS-5.44 treatment
increased levels of expression in the Arl1 overexpres-
sing strain for FIG2, MUC1, VBA5 and YJU2 with the
qRT-PCR transcript levels being 50 - 200% higher
when compared with the microarray data. Decreased
transcript levels were confirmed for CMD1, COX5B,
HSP30, RCR1 and UBI4, using qRT-PCR (Additional
file 1: Figure S10).ARL1 overexpression reduces COS-induced
membrane permeabilization
A Sytox permeability assay was performed in the wild
type (BY4743) and ARL1 strain after overnight growth in
Figure 5 Biological processes associated with differentially expressed genes on Arl1 overexpressing strain when exposed to chitosan
oligosaccharide (COS). A node represents a biological process significantly enriched (FDR≤ 0.1, see Methods). Boxes on the side show summary
of the main biological process found in a cluster. The node size correlates to the number of genes annotates to that functional category. Red and
blue node border colours indicate enrichment of biological processes in up- and down-regulated genes, respectively. The width of the edge
correlates to the degree of gene overlap between the 2 connected categories. If the overlap coefficient is less than 0.5, edges are not shown (see
Methods). Cluster membership is shown by node color, where clustering is based in degree of overlap among categories.
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Figure 6 Sytox cell permeability assay of COS-5.44 resistant
Arl1 overexpressing strain vs. vector control (BY4743). A) Vector
control (BY4743) shows significantly higher cell membrane
permeability compared with overexpressing strain Arl1 (B) after
treatment with chitosan oligosaccharide (COS-5.44). A large increase
in cell membrane permeability is observed in the wild type as
chitosan oligosaccharide concentration is increased (A). The first
peak (left) in the graph corresponds to the background fluorescence
and the second peak (right) corresponds to the Sytox signal
observed inside the cell due to nucleic acid binding. C) Overlay of 3
replicates of each strain Sytox assay after exposure to112.5 μg/ml
COS-5.44. Student t-test of C) data, P-value < 0.0101.
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ity [37] see Methods. Sytox Green fluoresces once bound
to nucleic acids. It only enters cells with compromised
plasma membranes and is excluded from live cells with
an intact plasma membrane. Wild type cells treated with
COS-5.44 were Sytox-positive indicating that COS treat-
ment causes membrane permeability (Figure 6A and
6C). There was a dose dependent increase in the intra-
cellular Sytox fluorescence signal as a function of COS
concentration (Figure 6A). Although there was some
Sytox signal in the Arl1 overexpressing strain, it was sig-
nificantly lower than that in the wild type at the highest
concentration of COS tested (112.5 μg/ml; P-value < 0.011,
student t- test) (Figure 6C). This indicates that overex-
pression of Arl1 provides protection against COS-induced
cell permeability and damage.Yeast stress responses and COS-5.44 resistance
Given our observation that the transcriptional changes
in the overexpressing strains include genes involved in
stress responses, we investigated whether these strains
had activated well known stress responses that could po-
tentially account for the strain’s resistance to COS-5.44
treatment. To test this hypothesis, the wild type strain
(BY4743) was exposed to a sub-lethal dose of different
primary stresses previously reported by Berry and Gasch
2008, [38] followed by exposure to acute stress.
The wild type strain was first exposed to sub-lethal
doses of stress (mild primary stress) followed by 2 h ex-
posure to COS-5.44 (acute secondary stress). The pri-
mary mild stresses tested were: 0.25 M and 0.5 M NaCl,
1 M sorbitol, 0.003% and 0.006% H2O2 for 60 min, 37°C
for 15 min and 30°C control (see Methods).
Wild type cells did not acquire resistance to COS-5.44
treatment after exposure to sub-lethal doses of different
primary stressors (Additional file 1: Figure S11), al-
though there was some variation in how the different
primary stressors affected yeast growth when challenged
with COS-5.44. In the 30°C control treatments, there
was a similar amount of growth in both the control
medium (0.5X YPD pH 5) and vehicle (1% DMSO);
Figure 7 Effect of osmotic stressors, antifungal agents and oxidative stress on the growth of Arl1 overexpressing and wild type cells.
A) Arl1 overexpression confers resistance to COS-5.44 at a concentration that inhibits growth of the vector control cells. The Arl1 overexpressing
strain is as sensitive as the wild type cells to the tested antifungal compounds: B) Amphotericin B; C-D) Fluconazole; E-F) Terbinafine.
Overexpression of ARL1 confers tolerance to H2O2 (G) compared with the wild type. All assays were done in YPD except COS-5.44 that was done
in 0.5X YPD. Optical density readings were taken every 15 min over 20 hrs using a Tecan Genios reader. Tecan ODs were converted to
conventional 1 mm path length cuvette ODs using a calibration function provided by Ericson et al. 2010, [24]. Three colonies of each strain were
grown in triplicate and compared with the wild type grown under the same conditions. YPD - Yeast Peptone Dextrose Broth.
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observed growth inhibition (Additional file 1: Figure
S11A). After stressing the wild type cells for 15 min at
37°C, they could withstand 91.1 μg/ml of COS-5.44
and had a similar growth rate as wild type cells, but in-
creasing COS concentrations dramatically inhibited
growth rates (Additional file 1: Figure S11B). When the
highest concentration of NaCl (0.5 M) was used as the
primary stress, the effect of 112.5 μg/ml of COS-5.44
was increased, similar to what was observed when stres-
sing cells for 15 min at 37°C (Additional file 1:
Figure S11C). The addition of H2O2 slowed growth ofthe wild type cells and H2O2 pre-treatment did not ap-
pear to provide resistance to COS-5.44 (Additional file 1:
Figure S11E-F).
In contrast with the other stressors, sorbitol (1 M)
stress decreased growth in both untreated and COS-5.44
challenged cells (Additional file 1: Figure S11D). It
should be noted that sorbitol primary stress does appear
to provide some protection against the higher concen-
trations of COS with cells growing as well in the higher
as the lower concentrations of COS, a property not
observed for the other stressors. The osmotic stress gen-
erated by sorbitol treatment is known to activate other
Figure 8 COS-5.44 has a synergetic inhibitory effect on cell
growth when used in combination with Fluconazole. A) Growth
curves of wild type strain (BY4743) growth in the vehicle, COS-5.44
(77 μg/ml), Fluconazole (16 μg/ml) and COS-5.44 + Fluconazole
(77 + 16 μg/ml, respectively). B) Growth curves of wild type strain
(BY4743) growth in the vehicle, COS-5.44 (84 μg/ml), Fluconazole
(20 μg/ml) and COS-5.44 + Fluconazole (84 + 20 μg/ml, respectively).
Optical density readings were taken as described in Figure 3.
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our results show that sorbitol pre-treatment provides
some protection against COS (Additional file 1: Figure
S11D)[39]. The sorbitol results are consistent with the
findings of Zakrzewska et al. 2007, [23] who found that
when HOG pathway mutants and wild type cells, were
exposed to 1 M sorbitol, partial protection against chito-
san was observed. Overall, these results suggest that the
COS-5.44 stress response is different from the previously
described environmental stress responses and as a result,
most pre-stresses do not confer resistance to COS.ARL1 resistance to other antifungal compounds
or stresses
To test whether overexpression of ARL1 confers resist-
ance to other antifungal agents, cationic compounds, or
osmotic stresses, wild type (vector control) and ARL1
overexpression strain cells were grown in the presence
of these perturbations. Overexpression of ARL1 did not
confer resistance to NaCl, sorbitol or LiCl compared
with the vector control (data not shown). Overexpres-
sion of ARL1 does confer resistance to COS-5.44 at high
concentrations (112.5 μg/ml) where the vector control is
unable to grow (Figure 7A). Interestingly, the ARL1
overexpression strain is as sensitive to Amphotericin B
(12 μg/ml, Figure 7B) and Terbinafine (16 (not shown),
8 and 4 μg/ml, Figure 7E and F) as the wild type cells.
The ARL1 overexpression strain appears to be slightly
more sensitive than the vector control to Fluconazole
(32, 28, (not shown) 24 and 20 μg/ml, Figures 7C and
D). These results suggest that the resistance to COS
resulting from ARL1 overexpression is specific and does
not extend to other antifungal compounds that disrupt
fungal cell membranes [40]. Overexpression of ARL1
allows cells to withstand H2O2 perturbation slightly bet-
ter (12%) than control cells suggesting that ARL1 over-
expression may be providing some protection against
oxidative stress (Figure 7G).
Synergistic interaction of COS-5.44 with fluconazole
Because COS-5.44 and Fluconazole have different modes
of action, we examined the effect of treating cells with
both compounds simultaneously to test if these two
compounds might interact synergistically. We quantified
the degree of interaction across different concentrations
in a dose response matrix for each drug interacting
with itself and with the other drug (Additional file 2:
Table S8 - S11). At concentrations where either drug
only weakly inhibits cells growth (i.e. COS inhibits
growth ≤ 15% while Fluconazole inhibits ≤ 9%) when used
in combination, a dramatic decrease in cell growth is
observed (Figure 8A,B). Using the area under the growth
curve as a metric, the combination of COS-5.44 and
Fluconazole act in a synergistic fashion since the
combination of both drugs inhibits growth much more
(i.e. 45 to 86% inhibition) than the sum of growth inhib-
ition caused by each compound individually.
Discussion
We have applied multiple comprehensive chemoge-
nomics assays in yeast to identify the gene targets of
COS-5.44. Unlike other antifungal drugs tested with the
same approach [24] where typically 3–10 genes are iden-
tified as potential drug targets, we found a much larger
gene set (39) of yeast deletion strains highly sensitive to
COS-5.44. The most sensitive heterozygous deletion
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our case, we identified 17 heterozygous deletion strains,
suggesting that COS does not target a single specific
protein as its antifungal mode of action. In a previous
global fitness assay similar to the HIP-HOP assay, 101
homozygous strains were sensitive after 9 h (~ 6–7 gen-
erations) of exposure to 25 μg/ml of 10 kDa chitosan.
Very few heterozygous strains were identified as sensi-
tive to chitosan [23]. The differences seen in our results
compared to those of Zakrzewska et al. [23] are likely
due to a number of different experimental parameters.
First, there were differences in the form and concentra-
tion of COS used, (i.e. a lower concentration and larger
molecular weight of COS was used in that study [23]).Figure 9 Potential mechanisms of COS resistance resulting from the o
model, ERG24 overexpression would reduce membrane permeability by alt
BCK2, MSG5 and RBA50 either alone or in combination, could detect COS b
additional changes that reduce membrane permeability. Overexpressing th
transcripts related to energy production (e.g. ATP synthesis and mitochond
the blue boxes). A large number of genes involved in cell division (mitosis
up-regulated in the COS resistant overexpression strains (examples listed in
properties similar to a mammalian integrins.As we described earlier, the physiochemical properties of
COS such as degree of deacetylation and molecular
weight are known to affect COS’s biological activity
[16,41,42]. Second, the treatment period used in the
Zakrzewska et al. study was shorter than in the one used
in our study (9 vs. 40 hrs equivalent to ~ 6–7 and 20
generations respectively). The shorter exposure time
could explain the low number of chitosan sensitive
heterozygous deletion strains found by these authors
since the subtle phenotypes of the heterozygous dele-
tions strains often require longer growth periods to re-
solve fitness differences between strains [43]. Finally, the
lower threshold for the identification of sensitive strains
(i.e. those having a log2 ratio of ≥ 1.585) used byverexpression of specific genes identified in this study. In this
ering the composition and fluidity of the plasma membrane. ARL1,
inding to the membrane and subsequently induce transcriptional and
ese strains that are resistant to COS results in a down regulation of
rial activity; examples of specific down-regulated genes are listed in
and meiosis), cell cycle and cytoskeleton are transcriptionally
the orange boxes). Integrin refers to yeast proteins that have
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number of homozygous strains they determined to be
chitosan sensitive.
Several of the genes sensitive to COS in our HIP-HOP
assay and resistant in the multicopy suppression assay
were enriched for proteins targeted to membranes. This
is not surprising given that COS likely perturbs mem-
brane integrity. COS might also be creating oxidative
stress leading to the accumulation of damaged proteins
that are degraded by the proteosome. Protein degrad-
ation/proteosome functions were among the biological
processes enriched in the HIP-HOP assays (Figure 2C).
We selected 5 of the confirmed overexpressing strains
that provide resistance to COS to uncover any changes
in their gene expression profiles that might give insights
into COS’s mechanism of action. ARL1 (YBR164C) was
found to be sensitive to COS as a deletion strain in the
HOP assay and resistant in the MSP assay in this study
and was found to be sensitive to chitosan as a homozy-
gous deletion strain in a previous study [23]. We con-
firmed that an ARL1 deletion strain was sensitive to
COS-5.44 and overexpression of ARL1 conferred resist-
ance to COS-5.44 (Figures 3B and 3D). We believe the
identification of this gene does provide information into
the molecular mechanism of COS-5.44. Arl1 is a G pro-
tein and soluble GTPase and is a member of the Ras
superfamily [28,44]. Arl1 is highly conserved in all
eukaryotes with 65% homology to human ADP-
ribosylation factor-like protein 1 (Arl1). Arl1 has been
shown to be associated with the trans-Golgi and is
thought to be required for endosome-Golgi trafficking
[45,46]. Arl1-GTP recruits specific receptor proteins to
the membrane surface by binding to their GRIP
domains, although in yeast, no specific Arl1 binding re-
ceptor proteins have yet been identified [44,45]. Muta-
tions in yeast ARL1 are not lethal [28] but ARL1
mutants do show mild defects in localizing proteins to
vacuoles as well as defects in potassium uptake [44,46-48].
arl1 mutants have also been shown to be more sensitive
to antifungal agents such as Hygromycin B [46]. Arl1 can
be myristolayted and we hypothesize that through myris-
toylation, the soluble form of the GTPase could be bound
to the membrane bilayer. In this way ARL1 could act as a
sensor and modulate membrane trafficking at the onset of
COS 5.44 induced membrane permeabilization (Figure 9).
Arl1 (Arl1p, PDB id 1moz) has been predicted to weakly
associate with membranes (deltaG of -4 kcal/mol without
ligands for the dimer) with the N-terminal residues (N-
myristoyl glycine) of each dimer binding to the membrane
[27,49,50]. GTPases are known to be involved in signal
transduction pathways in filamentous fungi and yeast.
These proteins are also involved in conidiation, a process
that is enhanced by chitosan treatment in filamentous
fungi [8]. When the ARL1 gene is overexpressed and yeastcells are challenged with COS, a large set of genes related
to cytoskeleton organisation (e.g. microtubule dynamics)
and stress sensing are up-regulated (Figure 5). These
genes are also involved in cell division (mitosis and mei-
osis) and the cell cycle. This could explain the ability of
chitosan to enhance sporulation [28,44].
ERG24, which encodes C-14 sterol reductase, is a gene
involved in ergosterol biosynthesis. Because ergosterol is
a unique lipid in fungal membranes it is a classical target
of many antifungal compounds. In a previous study,
while ergosterol content was not associated with resist-
ance to chitosan, in some filamentous fungi saturation of
free fatty acids was associated with resistance [51]. Free
fatty acid desaturases lower membrane fluidity and desa-
turase mutants have been found to confer resistance to
chitosan in N. crassa [51]. Membrane patches rich in er-
gosterol and other lipids alter membrane fluidity and are
important for correct membrane function [52]. It also
has been shown that an increase in sterol biosynthetic
capacity results in an increase in the availability of fatty
acids [53]. We can envision that overexpression of
ERG24, a key gene in the ergosterol biosynthetic path-
way, could increase the size/presence of ergosterol rich
membrane rafts and fatty acid content making the mem-
brane less fluid and therefore more resistant to COS.
For both yeast and filamentous fungi, the plasma
membrane is the primary target for chitosan. In yeast,
chitosan causes cell leakage and stops cell growth [22].
In filamentous fungi, chitosan permeabilizes the mem-
brane in an energy dependent manner and kills cells of
sensitive species such as N. crassa conidia [54]. A recent
study by Palma-Guerrero et al. 2010, [51] found that
membrane fluidity is a key factor in the antifungal action
of chitosan with fluid fungal membranes binding more
chitosan than less fluid ones. Chitosan crosses the fungal
cell wall and binds to membrane lipids with a preference
for negatively charged ones [51]. Chitosan permeabilizes
the membrane when the concentration reaches a critical
level [55,56]. Our study identifies pathways involved in
membrane structure and signalling that are affected by
COS. The Sytox uptake experiments confirm that mem-
brane permeability is increased when cells are exposed
to COS and that overexpression of ARL1 suppresses the
increase in membrane permeability caused by COS
(Figure 6).
While our work and previous studies have shown that
chitosan induces stress responses in yeast and other
fungi, our study shows that pre-treatment with any of
the well characterized environmental stresses (thermal,
salt, osmotic and oxidative) does not provide resistance
to COS-5.44 in yeast (Additional file 1: Figure S11).
Therefore, the changes induced by COS would appear to
be different from previously described environmental
stress response pathways.
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is to increase the permeabilization of membranes, we
speculate that several of the genes we have identified in
this study are involved in a cellular response that
reduces permeabilization of the membrane and/or miti-
gates the damage induced by the permeabilization. For
example, ARL1, BCK2 and MSG5 could be part of a
sensing and signalling mechanism(s) that detects COS
binding to the membrane that induces transcriptional
and other changes to reduce membrane permeability.
ERG24 could be reducing membrane permeability by
affecting the composition and fluidity of the membrane
(Figure 9). Ultimately, if COS concentrations are too
high, the cellular response would be insufficient to pre-
vent membrane permeabilization and cell death would
ensue - possibly as a result of the release/leakage of oxy-
gen radicals from the mitochondria. While the exact
mechanism of cell death by COS is still unknown, it
appears to be a respiration/ATP-dependent process in
filamentous fungi [54]. Overexpressing strains resistant
to COS display down-regulated genes related to energy
dependent processes (ATP synthesis, mitochondrial ac-
tivity, etc.) (Figure 5; Additional file 1: Figures S5-S9;
Additional file 2: Table S6). In this sense, the overexpres-
sing strains would mimic the effect of treatments such
as sodium azide and low temperature that inhibit oxida-
tive respiration and chitosan damage to fungal cells [54].
Interestingly, the ARL1 overexpression strain also shows
increased resistance to certain forms of oxidative stress
such as H2O2 (Figure 7G). The transcriptome analysis of
several of the overexpressing strains suggests that resist-
ance to COS involves generation of less ROS by redu-
cing oxidative respiration as well as reducing cell
responses to ROS.
A comparison of the gene targets found in the HIP-
HOP screens in this study to genes found in similar
screens for other fungicides that act at the cell mem-
brane (e.g. Amphotericin B, Fluconazole and Terbina-
fine) suggests that COS may have a different mechanism
of action than these other drugs [57]. In support of this
hypothesis, we have found that the ARL1 overexpression
strain does not provide resistance against Amphotericin
B, Fluconazole or Terbinafine (Figure 7B-F). This sug-
gests that COS might be an effective antifungal agent in
strains that are resistant to the other perturbing cell
membrane compounds.
Fluconazole, Terbinafine and Amphotericin B antifun-
gal activity involves the targeting of ergosterol, the prin-
cipal cell membrane sterol of fungi, by different
mechanisms. Fluconazole (an triazole) inhibits 14α-
demethylase (lanosterol demethylase, Erg11), a fungal
cytochrome P450 dependent enzyme, and depletes cell
membrane ergosterol resulting in reduced membrane
fluidity, and the accumulation of 14α-demethylatedsterols that are toxic to the cell. This leads to growth ar-
rest and eventual fungal cell death [58,59]. Terbinafine
inhibits squalene monoxygenase (Erg1), an enzyme re-
sponsible for conversion of squalene epoxide, a precur-
sor to lanosterol in the ergosterol synthesis pathway
[59]. Amphotericin B targets the fungal cell membrane
by directly binding to ergosterol, forming complexes that
intercalate the cell membrane, resulting in formation of
pores and leakage of intracellular contents [60,61]. COS
appears to perturb the cell membrane possibly through
the ergosterol pathway, by targeting ERG24, a gene that
encodes for C-14 sterol reductase [62].
Because COS seems to have a distinct mode of ac-
tion compared with other antifungals, we were inter-
ested in seeing its inhibitory effect when used in
conjunction with another antifungal drug. We tested
COS and Fluconazole in combination (as well as on
their own), and saw a strong synergism between them.
That is, at concentrations where either drug alone had
little inhibitory effect, a strong inhibitory effect that
was much greater than additive was observed when
they were combined (45 to 86% growth inhibition;
Figure 8A,B). One possible explanation for this synergy
might be that the increased membrane permeability
induced by COS allows more Fluconazole to penetrate
the cell membrane to inhibit 14α-demethylase that in
turn further reduces membrane fluidity and increases
the production of toxic sterols.
Conclusions
The results of this study have provided insights into the
molecular mechanisms of the antifungal modes of action
of COS. Some of the pathways COS appears to affect in-
clude sensing, signalling, and the composition of the cell
membrane (Figure 9). Our results suggest that COS does
not have a single specific gene target. We provide evi-
dence that COS increases cell membrane permeability
and that the overexpression of ARL1 can reduce the per-
meability induced by COS. Resistance to COS does not
confer resistance to other antifungal compounds that
disrupt the fungal cell membrane such as azoles, poly-
enes and Terbinafine. COS can synergize with other
antifungal agents such as Fluconazole suggesting that
COS could be considered as alternative antifungal treat-
ment to fungal pathogens that are resistant to other anti-
fungal compounds or be used in combination with other
antifungal agents to enhance their activity.
Methods
Chitosan oligosaccharide
Chitosan oligosaccharide (COS-5.44) (5.44 KDa, PDI (poly
dispersity index) = 1.14 and 97% degree of deacetylation)
was kindly provided by Dr V. Tikhonov (Laboratory of
Physiologically Active Biopolymers, A. N. Nesmeyanov
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emy of Sciences, Moscow, Russia). COS-5.44 was pre-
pared as described by Tikhonov et al. 2006, [20]. For the
experiments performed in this study, a COS-5.44 stock
solution (25 mg/ml) in 50% DMSO was prepared, ali-
quoted and stored at −20°C.
Chitosan
Chitosan (T8s) with a molecular weight of 70 kDa and
80% degree of deacetylation was obtained from Marine
BioProducts GmbH (Bremerhaven, Germany). Chitosan
was prepared as described by Palma-Guerrero et al. 2008,
[55]. Each batch of dialyzed and autoclaved chitosan was
stored at 4°C for a maximum of 2 weeks.
Yeast sensitivity to COS-5.44 and chitosan
A pre-screen of COS-5.44 and chitosan (T8s) in wild
type yeast (BY4743) was performed as described in
Pierce et al. 2007, [43] to determine the antifungal activ-
ities of these two compounds that have different mo-
lecular weights and degrees of deacetylation. For the
pre-screen of COS-5.44, concentrations from 62 μg/ml
to 125 μg/ml of COS-5.44 were tested (Figure 2B). 98 μl
of cell mix at an initial OD600 of 0.0625 in 0.5X YPD pH
5 (5 g bacto yeast extract, 10 bacto peptone and 10 g
dextrose in 1 l distilled water [63]) was added to each
well of a 96 well plate (Nunc) then 2 μl of the corre-
sponding COS-5.44 stock were added, including carrier
controls (50% DMSO and 0.25 mol/l HCl neutralized
pH5.6). The chitosan (T8s) screen followed the same
protocol, with the slight difference in volume of cell mix
(97 μl) added and chitosan (T8s) stock (3 μl). Con-
centrations from 125 μg/ml to 162.5 μg/ml of chitosan
(T8s) were tested (Additional file 1: Figure S1) Cells
were grown at 30°C in a shaking-spectrophotometer
(Tecan), with readings taken every 15 min for 24 hrs.
Tecan ODs were converted to conventional 1 mm path
length cuvette ODs using a calibration function provided
by Ericson et al. 2010, [24]. The COS-5.44 pre-screen
was performed to identify an IC70-90 and IC10-20 of
COS-5.44 in the BY4743 to be used in the multicopy
suppression and deletion profiling (HIP-HOP) respect-
ively (Figure 2B).
Haploinsufficiency and homozygous profiling
(HIP-HOP) assay
Haploinsufficiency and Homozygous profile assays, gen-
omic DNA purification, PCR amplification of barcodes,
array hybridization, analysis and confirmation were per-
formed as described in Ericson et al. 2010, [24]. The
homozygous collection was grown for 5 generations (ap-
proximately 10 hrs) and the heterozygous collection for
20 generations (approximately 40 hrs), as these periodsof time have been found to be optimal to allow each col-
lection to resolve growth differences [43].
Experiments were performed in duplicate. Yeast dele-
tion strains with log2 ratio of 3.5 or higher (Highly sen-
sitive COS-5.44 deletion strains) were selected for
individual confirmation. A log2 ratio of 3.5 represents an
approximately 11- fold less abundance of the deletion
strain after COS treatment.
Multicopy suppression profiling and screen conditions
MSP screen, plasmid isolation, Affymetrix TAG4 ar-
ray hybridization, microarray results analysis and con-
firmation followed the protocols described by Hoon
et al. 2008, [25] and Ericson et al. 2010, [24].
Transformation of candidate resistant genes for
overexpression in yeast
Sixty-eight genes were identified with MSP as possible
candidates to confer resistance to COS-5.44 (Additional
file 1: Figure S2). To confirm which of the 68 genes con-
ferred resistance, each gene was individually overex-
pressed in yeast. For this purpose E. coli strains carrying
the genes of interest were obtained from the MoBY-ORF
2 μ collection, kindly provided by Sarah Barker from the
Boone lab [30]. 57 of the 68 candidate genes were avail-
able in the MoBY-ORF 2 μ collection and thus 11 of the
genes of interest were not present in this collection and
could not be tested.
Individual colonies of each E. coli strain were grown in
selective media in 2YT (1% Yeast extract, 1.6% Bacto
tryptone, and 0.5% Sodium) + 0.4% Glucose +Carbenicil-
lin (200 mg/ml, SIGMA) +Kanamycin (50 mg/ml,
SIGMA) in 96 square well blocks (Greiner, Bio-one) at
37°C and 200–250 rpm. Cells were harvested (5 min,
4000 rpm) to proceed with DNA extraction. Macherey-
Nagel Multi-96 purification kit (MN Cat # 740 625.4)
was used to miniprep the plasmids, following the manu-
facturer’s protocol. Elution was done in 150 μl to
collect ~ 100 μl of purified DNA.
Each plasmid extract was double digested with EcoRI/
XhoI (New England BioLabs Inc.). Digested samples
were run on a 0.8% agarose gel to confirm vector and
ORF fragments size.
The confirmed plasmids were transformed into yeast
strain BY4743 (his3 1/his3 1 leu2 0/leu2 0 ura3 0/ura3 0
met15 0/+ lys2 0/+), using a 96 well yeast transformation
protocol as described by Gietz et al. 2007, [64]. Five
single colonies of each strain were grown overnight
in selective liquid media then archived in 15% glycerol
at −80°C.
Once overexpressing strains were obtained, confirm-
ation of resistance to COS-5.44 was performed
(Figure 1). Overexpressing strains were grown at differ-
ent concentrations of COS-5.44 previously found to be
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tested were 101.25, 106.28, 112.5, 118.75, 125.0 and
250.0 μg/ml. To ensure that the resistance was conferred
by the overexpressed gene, plasmid DNA was extracted
from two colonies of each overexpressing strains, and
transformed into E. coli. Amplified plasmids were
extracted using Genejet kit (Fermentas) following manu-
facturer protocol. Purified plasmids were double digested
as described. Confirmed plasmids were retransformed
into BY4743 and three single colonies were selected
and confirmed for COS-5.44 resistance as previously
described.
Sample collection and RNA extraction of
overexpressing strains
A confirmed colony of each overexpressing strain and
the wild type with the empty vector was grown over-
night at 30°C and shaking at 200–250 rpm. An overnight
culture was used to inoculate 3 flasks each with 400 ml
of 0.5X YPD pH 5. Cells were grown until the culture
reached an OD600 of 0.8 and a 100 ml sample was col-
lected (time zero). The remaining 300 ml were treated
with COS-5.44 (112.5 μg/ml) and 100 ml samples were
collected at 15, 30 and 60 min after treatment (Figure 1).
Cells were collected by centrifugation (5 min, 4000 rpm)
frozen with liquid nitrogen and stored at −80°C, for
RNA extraction and labeling. Once all samples were col-
lected a hot acid phenol-chloroform RNA extraction was
performed [65].
Microarray analysis (see below) of the COS treated
wild type cells found that the maximum number of dif-
ferentially expressed genes were obtained with the 60
min treatment with minimal loss of genes differentially
expressed at earlier time points but not at 60 min.
Therefore, for the overexpression strains, microarray
analysis was only performed on the untreated and 60
min COS treated samples.
cDNA and microarray sample preparation
cDNA synthesis and sample labeling for NimbleGen
4X72k yeast microarrays (Roche NimbleGen, Inc.; De-
sign ID A6186-00-01, TI4932 60mer expr X4) was per-
formed as described in the manufacturer’s protocol with
minor modifications. cDNA synthesis was performed
using 10 μg of total RNA. The sample labeling reactions
were done using 1 μg of double stranded cDNA. Three
cDNA biological replicates either with or without a 60
min exposure to COS-5.44 for each of the 5 overexpres-
sing strains as well as an untransformed wild type
BY4743 cells (vector control; for a total of 36 samples)
were hybridized to NimbleGen 4X72k microarrays
(Roche NimbleGen, Inc.). Microarrays were scanned
with a Genepix 4000B scanner (Molecular Devices Inc.
Sunnyvale, CA).Microarray data analysis
Raw images were obtained using GenePix Pro software
(Version 5.0, Molecular Devices Inc. Sunnyvale, CA). Raw
probe intensities (x, y and signal reports) were obtained
using NimbleScan software (v2.4, Roche NimbleGen, Inc).
Data preprocessing of 60mer oligonucleotide arrays was
performed using the BioConductor package Oligo [66].
Genes with significant expression difference compared
with the vector control (wild type, BY4743) were identified
for each overexpressing strain using the BioConductor
package Limma Linear models for microarray analysis,
[67], taking P-value≤ 0.05 and log2 fold change of ≥ 1 or
≤−1 as significant unless otherwise noted. The data dis-
cussed in this publication have been deposited in NCBI’s
Gene Expression Omnibus [68] and are accessible through
GEO Series accession number GSE32888 (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32888).
Hierarchical clustering
Hierarchical clustering of the data was performed using
the program Cluster 3.0 originally written by Eisen, [69],
modified by de Hoon, [70]. Expression data of the 5
overexpressing strains was clustered using city-block dis-
tance measurement and average linkage clustering
method. The resulting clusters were visualized using Java
TreeView [71].
Functional annotation of chemogenomic assays and
microarray results
The genome-wide profile of the COS-5.44 sensitive dele-
tion strains was examined using Gene Set Enrichment
Analysis GSEA, [29] to identify enriched biological pro-
cesses. GSEA has been considered advantageous for
quantitative genome-wide profiles because it can take
into account the entire profile, exploiting the weighting
of the genes (e.g. degree of sensitivity to a drug (i.e. fit-
ness defect), differential gene expression). Other func-
tional analysis methods focus on a list of genes that
satisfy the characteristic of interest. This would first re-
quire setting a threshold to divide the profile into lists of
genes that satisfy the characteristic of interest and those
that do not. It is often unclear how to choose an appro-
priate threshold, yet with GSEA, choosing such a thresh-
old is not required.
Deletion strains were mapped to genes using chromo-
somal feature data downloaded from the Saccharomyces
Genome Database (SGD) on April 16, 2011. Multidrug
resistance genes MDR, [57] were filtered from the
genome-wide profile of sensitive deletions strains to
COS, to identify biological process specific to COS re-
sponse. The list of all genes ranked by their fitness
defects was analyzed by GSEA v2.07 (4864 genes, with-
out MDR genes) [29]. Default parameters were used ex-
cept that minimum and maximum gene set size were
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annotation was obtained from Gene Ontology website
(http://berkeleybop.org/goose) on April 13, 2011. Add-
itional protein complex annotations based on consensus
across different studies were obtained from Benschop
et al. 2010, [72].
Enrichment maps were generated with Enrichment
Map Plugin v1.1 [73] developed for Cytoscape [74] with
default parameters. Nodes in the maps were clustered
with the Markov clustering algorithm, using an overlap
coefficient computed by the plugin as the similarity
metric (coefficient < 0.5 were set to zero) and an inflation
parameter with value of 2. For each cluster leading edge
were computed as in Subramanian et al. 2005, [29] for
each member of a node. The top 10 leading edge genes
associated with the most nodes in the cluster are shown
in the bar plot (if less than 10 genes, all are shown).
A functional analysis (i.e. GSEA [29]) was performed as
described above for the transcriptional profiles of the wild
type (BY4743) exposed to COS-5.44 and the 60 min chito-
san data set from Zakrzewska et al. 2005, [22] that was
performed on X2180-1A, MATa SUC2 mal gal2 CUP
cells. The set of environmental stress response genes ESR,
[75], were filtered from the transcriptome data sets to
identify the biological processes enriched by COS or chit-
osan treatment apart of the general stress response of
yeast. Enrichment maps were generated with Enrichment
Map Plugin v1.1 [73] developed for Cytoscape [74] with
the following parameters: FDR<1%, p-value < 0.005 and
using an overlap coefficient computed by the plugin as the
similarity metric (coefficient < 0.5 were set to zero). En-
richment maps were compared with the comparison func-
tion of the Enrichment Map Plugin v1.1 [73].
A similar functional analysis was performed on the
whole transcriptome dataset of each overexpressing strain.
As was described above, the set of environmental stress
response genes were filtered from the transcriptome data
set. An additional enrichment analysis of significantly up-
or down-regulated transcripts (P-value≥ 0.05 and log2 fold
changes≥ 1 or≤−1) was also performed using the single
enrichment analysis tool of Babelomics [35,36]. All default
parameters were used.
Quantitative RT-PCR
Quantitative reverse transcription – PCR (qRT-PCR)
verification of the microarray results for selected genes,
was performed using KAPA SYBR FAST (KAPA Biosys-
tems) in a CFX384 real-time PCR detection system
(Bio-Rad), with two biological replicates from wild type
(vector control BY4743) or Arl1 overexpressing strain
that were either untreated or exposed to COS-5.44 for
60 min. Each RT qPCR reaction had 200 pg of cDNA, 5
μL of KAPA SYBR FAST master mix (2x), 300 μM of
each primer and water to have a final volume of 10 μLper reaction. Cycling conditions used were as follows:
95°C for 3 min, followed by 40 cycles of 95°C for 3 s and
60°C for 30 s then 95°C for 10 s. All the reactions were
performed in triplicate, using primers for the following
genes: ACT1, ARL1, CMD1, COX5B, ERV25, FIG2,
HSP30, MUC1, RCR1, RPL32, SPT15, UBI4 and VBA5.
Primers were designed using Primer-BLAST Developed
at NCBI uses Primer 3, [76]. See Additional file 2: Table
S6 for the sequences of the primers used. The average of
three technical replicates was normalized to four in-
ternal control transcripts, ACT1, ERV25, RPL32, SPT15,
there were not significant differences among internal
controls therefore all were used for normalization. Data
was analyzed using CFX Manager (Bio-Rad laboratories,
Inc).
Cell permeability assay
Plasma membrane permeability was measured by
SYTOX Green uptake as described by Thevissen et al.
1999, [37] with modifications. S. cerevisiae cells of the
wild type and overexpressing strain Arl1 were grown in
the presence of COS-5.44 (91.1, 101.25, 106.28 and
112.5 mg/ml) and vehicle control (1% DMSO). Cultures
of the overexpressing strain Arl1 and wild type (B4743)
with empty vector were set up at initial OD of 0.0625
and grown overnight (17 hrs). After COS-5.44 treatment
the cells were pelleted by centrifugation (5 min,
4000 rpm) and washed three times in 0.1 M Tris–HCl,
pH 7.0. Two hundred microlitre aliquots of the yeast cell
suspension was incubated with 0.2 μM SYTOX Green in
96-well microplates for 30 min at 30°C with periodic agi-
tation in the dark. Three replicates of each strain were
performed. Fluorescence was measured using a Guava
easyCyte flow cytometer (Millipore). The green fluores-
cence filter set 488 nm (excitation) and 520 nm, (emis-
sion) was used. Fluorescence data was analyzed with the
software FlowJo (V9.3.1, Tree Star, Inc.).
Stress response and COS-5.44 resistance
To verify if the activation of the environmental stress re-
sponse (ESR) provides resistance to COS-5.44 treatment,
the wild type strain (BY4743) was exposed to sub-lethal
doses of primary stresses previously reported by Berry
and Gasch 2008, [38] to provide resistance to more se-
vere stresses. The yeast wild type strain was exposed to
sub-lethal doses of stress (mild primary stress) then cells
were exposed to chitosan oligosaccharide treatment (se-
vere secondary stress). The primary mild stresses tested
were: 0.25 M and 0.5 M NaCl, 1 M sorbitol, 0.003% and
0.006% H2O2 for 60 min, 37°C for 15 min and 30°C con-
trol. Yeast cells were collected by centrifugation (5 min,
4000 rpm) then exposed to the secondary stress treat-
ment COS-5.44 for two hours (91.1, 101.25, 0.1068 and
112.5 μg/ml). After the secondary stress, cells were
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growth rates measured.Resistance to other antifungal and cationic compounds
To ask if the overexpression of ARL1 conferred resist-
ance to other cationic compounds, the wild type
and ARL1 overexpression strain were grown in the
presence of other cationic compounds (as described in
section 3.2).
A dose response assay was performed in the wild type
and overexpression strain ARL1, as previously described
screen protocol, using the following compounds: NaCl
(0.5 and 1 M); sorbitol (1 and 2 M); LiCl (0.01 M);
hygromycin B (25, 12, and 6 μg/ml); Amphotericin B
(25, 12 and 6 μg/ml); Fluconazole (32, 28, 24 and 20 μg/
ml); Terbinafine (16, 8 and 4 μg/ml); H2O2 (0.012%
0.006%); 1% SDS (0.05, 0.025 and 0.012%).Interaction between COS and fluconazole
For COS-5.44, a concentration range of 35–105 μg/ml
and for Fluconazole, a concentration range 4–24 μg/ml
was used. Stocks for each drug treatment were prepared
in 12.5% DMSO resulting in a final concentration of 1%
DMSO. Wild type yeast (BY4743) was grown overnight
and diluted at an initial OD600 of 0.0625 in 0.54X YPD
pH 5. 92 μl of cell mix was aliquoted to each well of a
96 well plate (Nunc), and 4 μl of the corresponding
COS-5.44 and/or Fluconazole stock were added in a
7 × 12 dose response matrix. Two dose response matri-
ces were performed: self-self (COS-5.44 – COS-5.44 and
Fluconazole – Fluconazole) and two replicates of the
COS-5.44 and Fluconazole matrix. Cells were grown at
30°C in a shaking-spectrophotometer (Tecan), with
readings taken every 15 min for 24 hrs. We used the
area under the growth curve as a metric to measure
growth inhibition and drug interaction.Additional files
Additional file 1: Figures S1 – S11 and their corresponding figure
legends.
Additional file 2: Tables S1 – S13 and their corresponding legends.Abbreviations
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